Greater cannabis use disorder symptom severity was associated with higher probability of receiving clinical diagnosis and treatment from primary care providers.
Primary care providers, healthcare system administrators, screening program developers, and cannabis users.
Severity predicts actionMore CUD symptoms increased probability of receiving clinical diagnosis and treatment
What the researchers found
The probability of a medical provider diagnosing and treating CUD increased with the number of substance use disorder symptoms endorsed, suggesting that brief screening followed by standardized assessment can support appropriate clinical responses.
Why it matters
CUD is widely underdiagnosed in primary care. Demonstrating that symptom severity predicts clinical action supports integrating brief cannabis screening into routine primary care visits.
The numbers in context
The study tested associations between SUD symptom count and probability of clinically-documented CUD diagnosis and treatment in a primary care sample.
How the study worked
Cross-sectional analysis of primary care patients examining the relationship between cannabis screening results and clinical documentation of CUD diagnosis and treatment.
Who was studied
Primary care patients screened for cannabis use and assessed for substance use disorder symptoms.
What this study cannot tell us
Cross-sectional design; primary care providers may vary in screening and diagnostic practices; documentation may not capture all clinical encounters about cannabis use.
How to read the evidence
Cross-sectional primary care analysis; provides evidence supporting screening implementation.
When this study was published
Recent study supporting cannabis screening in primary care settings.
The bigger picture
Integrating cannabis screening into primary care could improve early CUD identification and treatment, similar to how alcohol screening (SBIRT) has become standard practice.
Replication
Supports growing evidence for integrating cannabis screening into primary care practice.
Funding
Not specified
Conflicts of interest
Not specified
Questions still open
- What screening threshold best predicts clinical CUD?
- Does screening alone change provider behavior?
- How does stigma affect primary care CUD diagnosis rates?
Read the original research
Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample.
Drug and alcohol dependence, 251, 110946
Citation
Matson, Theresa E; Williams, Emily C; Lapham, Gwen T; Oliver, Malia; Hallgren, Kevin A; Bradley, Katharine A. (2023). Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample.. Drug and alcohol dependence, 251, 110946. https://doi.org/10.1016/j.drugalcdep.2023.110946